POS-254 CLINICAL AND SAFETY OUTCOMES WITH APIXABAN VERSUS WARFARIN BY EGFR IN ADULTS WITH ATRIAL FIBRILLATION
HEALTH POLICY AND PLANNING
2022
JAMA
Nat Rev Cardiol
Circulation